REMEGEN

Forecast & Rating16 analysts currently cover REMEGEN, with about 81.3% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$116.95, about 66.4% upside from the current price of HK$70.30. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 62.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study REMEGEN closely still see room for the stock to rise. Data as of Sep 26, 2026; for reference only and not investment advice.